Vertex CF Drug, Kalydeco, Rejected as Therapy for Specific Group of Mutations by FDA
Cystic Fibrosis, News
Vertex Pharmaceuticals recently received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) stating that its supplemental New Drug Application (sNDA) could not be approved in its current ... Read more